Export restrictions imposed on certain APIs and formulations, including paracetamol, vitamin B1 and B12, are not applicable for units in special economic zones (SEZs), according to a commerce ministry circular.
On March 3, exports of 26 APIs and formulations, including paracetamol, vitamin B1 and B12, have been put under restricted category amid the coronavirus outbreak in China.
The Directorate General of Foreign Trade (DGFT), an arm of the ministry, said that it has received various representations from SEZ units and other exporters highlighting issues faced by them on account of the decision to put this export restriction.
"It is, therefore, clarified that the exports of restricted APIs and formulations made from these APIs are allowed from SEZ units," the circular said.
Imposing restrictions means export of these active pharmaceutical ingredients (APIs) and formulations require a licence from the DGFT.
SEZs, developed as export hubs, are treated as a foreign territory in terms of customs laws. These units import raw material and export final products.
The pharmaceutical industry has urged the government to lift these restrictions on the export of active pharmaceutical ingredients and formulations.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
